ArticleFrontiers in pediatrics2026
Autoinflammation with infantile enterocolitis associated with a novel CARD domain mutation in
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autoinflammation with Infantile Enterocolitis (AIFEC, OMIM#616050) is a rare autosomal dominant autoinflammatory disorder caused by gain-of-function mutations in the NLRC4 gene. The disease is characterized by recurrent systemic inflammatory flares with enterocolitis as a hallmark feature, though clinical presentations are broad and often nonspecific. Case presentation: This report describes a noteworthy case of a pediatric patient with rare NLRC4 gene mutation leading to AIFEC. The patient was a 2-year-and-4-month-old female who presented with recurrent fever, chronic diarrhea, mucous bloody stools, and multi-system involvement. She had a history of multiple infections since early childhood. Laboratory investigations indicated significantly elevated inflammatory markers and endoscopic examination revealed multiple ulcers in the ileocolonic region. Whole-exome sequencing identified a Conclusion: This case identifies a novel NLRC4 variant (c.167A > G, p.His56Arg) located in the CARD domain. Our findings expand the known mutational and phenotypic spectrum of AIFEC and add to emerging clinical evidence suggesting the potential utility of infliximab as a targeted therapeutic option for this rare autoinflammatory condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.